Advanced Reconstructive Surgery Alliance
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Advanced Reconstructive Surgery Alliance sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Advanced Reconstructive Surgery Alliance: 3 sponsored US clinical trials, 2 recruiting.
Advanced Reconstructive Surgery Alliance sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diaphragmatic Paralysis, with 2 trials.
Upper-quartile sponsor footprint
Advanced Reconstructive Surgery Alliance sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
NCT07012642
Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.
NCT06243718
A Chart Review to Evaluate the Safety and Efficacy of Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis
NCT06257589
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
What is open in the Advanced Reconstructive Surgery Alliance pipeline
2 recruiting of 3 indexed (67% open).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Diaphragmatic Paralysis (2 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Advanced Reconstructive Surgery Alliance: open-pipeline peers nationwide
Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
Advanced Reconstructive Surgery Alliance sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- Abbisko Therapeutics Co · 67% recruiting · 6 trials
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Alexander B Olawaiye, MD · 67% recruiting · 3 trials
Related
What to do with this Advanced Reconstructive Surgery Alliance page
3 registered trials is a research-attention snapshot, not an endorsement of Advanced Reconstructive Surgery Alliance or any single study.
- 2 of Advanced Reconstructive Surgery Alliance's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Diaphragmatic Paralysis is the condition Advanced Reconstructive Surgery Alliance studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diaphragmatic Paralysis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Advanced Reconstructive Surgery Alliance pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.